Table 2.
Demographic and clinical details of the former amputees
| Sex/Age, yr | Years Since Amputation | Years Between Amputation and Transplantation | Years Since Replantation/Transplantation | Side/Level of Amputation | Prosthesis Use | NPS | SF-MPQ | Pain Bursts | Pain Medication |
|---|---|---|---|---|---|---|---|---|---|
| Replanted participants | |||||||||
| M/62 | 7 | — | 7 | L/BE | — | 5 | 2 | 2 | Aleve |
| M/59 | 0.4 | — | 0.4 | L/BE | — | 27 | 0 | 10 | Neurontin |
| M/40 | 6 | — | 6 | L/BE | — | 20 | 4 | 9 | Tylenol |
| Transplanted participants | |||||||||
| M/39 | 17 | 13 | 4 | L/BE | + (before) | 3 | 0 | 0 | |
| M/50 | 9 | 2.6 | 6.5 | R/BE | + (before) | 30 | 6 | 10 | |
F, female; M, male; L, left; R, right; BE, below elbow; NPS, Neuropathic Pain Scale; SF-MPQ, short-form McGill Pain Questionnaire. Pain bursts were evaluated on a scale ranging from 0 = no pain to 10 = severe pain.